Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184040 · ClinicalTrials.gov registry record · NA
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
A NA study of Exercise and Addictive Behaviors, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT01184040: Completed NA study of Exercise and Addictive Behaviors, sponsored by UConn Health.
NCT01184040 is a NA study of Exercise and Addictive Behaviors that has completed, run by UConn Health. The registered enrollment target is 61 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01184040, a NA study of Exercise and Addictive Behaviors, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
Contingency Management (CM) is highly effective in promoting recovery from substance use disorders, but benefits tend to attenuate over time when CM is discontinued. Identifying modifications of CM delivery that can extend its benefits is an important goal. The goal of this study is to evaluate the use of reinforcements to increase physical activity, specifically walking. The study provides a standard CM intervention to promote walking for three weeks. After three weeks, a progressively increasing variable interval schedule of reinforcement will be evaluated for increasing the durability of effects of the initial CM intervention. We hypothesize that Variable Interval Prize Contingency Management will result in greater adherence to a walking goal of 10,000 steps per day at Week 15 and Week 24 compared to the Control Condition.
Conditions Studied
Interventions
- BEHAVIORAL VIP CM
Study Locations (1)
Connecticut
- UConn Heatlh Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01184040 record still lists
NCT01184040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 1 intervention - of which VIP CM is the first listed.
NCT01184040 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01184040 about?
NCT01184040 is a clinical study titled "Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement". Contingency Management (CM) is highly effective in promoting recovery from substance use disorders, but benefits tend to attenuate over time when CM is discontinued. Identifying modifications of CM delivery that can extend its benefits is an important goal. The goal of this study is to evaluate the ...
What is the current status of trial NCT01184040?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2010-05. Estimated completion is 2012-03.
What conditions does trial NCT01184040 study?
This clinical trial studies the following conditions: Exercise, Addictive Behaviors.
What interventions are being tested in trial NCT01184040?
The interventions under investigation include: VIP CM (BEHAVIORAL).
Who is sponsoring clinical trial NCT01184040?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01184040 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01184040's enrollment target sits among peer trials
61 25th of 57 higher than 33 of 57 other Exercise trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia